NZ336321A - Use of benzothiophene (raloxifene) for treating breast cancer - Google Patents
Use of benzothiophene (raloxifene) for treating breast cancerInfo
- Publication number
- NZ336321A NZ336321A NZ336321A NZ33632199A NZ336321A NZ 336321 A NZ336321 A NZ 336321A NZ 336321 A NZ336321 A NZ 336321A NZ 33632199 A NZ33632199 A NZ 33632199A NZ 336321 A NZ336321 A NZ 336321A
- Authority
- NZ
- New Zealand
- Prior art keywords
- breast cancer
- raloxifene
- benzothiophene
- treating breast
- medicament
- Prior art date
Links
- FCEHBMOGCRZNNI-UHFFFAOYSA-N 1-benzothiophene Chemical compound C1=CC=C2SC=CC2=C1 FCEHBMOGCRZNNI-UHFFFAOYSA-N 0.000 title 2
- 206010006187 Breast cancer Diseases 0.000 title 1
- 208000026310 Breast neoplasm Diseases 0.000 title 1
- GZUITABIAKMVPG-UHFFFAOYSA-N raloxifene Chemical compound C1=CC(O)=CC=C1C1=C(C(=O)C=2C=CC(OCCN3CCCCC3)=CC=2)C2=CC=C(O)C=C2S1 GZUITABIAKMVPG-UHFFFAOYSA-N 0.000 title 1
- 229960004622 raloxifene Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 208000030776 invasive breast carcinoma Diseases 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Use of a compound of Formula (I) as a medicament for preventing invasive breast cancer. The medicament may be administered at a concentration of 30-200mg/day, preferably 60mg/day.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2985096P | 1996-10-30 | 1996-10-30 | |
| GBGB9624800.0A GB9624800D0 (en) | 1996-11-29 | 1996-11-29 | Methods of preventing breast cancer |
| US4026097P | 1997-03-10 | 1997-03-10 | |
| NZ32904299 | 1999-06-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ336321A true NZ336321A (en) | 2000-11-24 |
Family
ID=27451565
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ336321A NZ336321A (en) | 1996-10-30 | 1999-06-16 | Use of benzothiophene (raloxifene) for treating breast cancer |
Country Status (1)
| Country | Link |
|---|---|
| NZ (1) | NZ336321A (en) |
-
1999
- 1999-06-16 NZ NZ336321A patent/NZ336321A/en not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9700885A (en) | New heteroaryloxazolidinones. | |
| AU5624699A (en) | Use of 5ht-6 antagonists | |
| TR200000129T2 (en) | Brand new spiroazabicyclic heterocyclic compounds. | |
| MY137348A (en) | Highly selective norepinephrine reuptake inhibitors and methods of using the same | |
| ZA975437B (en) | New pyridyl alkene and pyridyl alkine acid amides. | |
| RU2011138835A (en) | APPLICATION OF DERIVATIVE RAMAPICIN | |
| ES2128137T3 (en) | PROPIOPHENONE DERIVATIVES AND PROCEDURES FOR ITS PREPARATION. | |
| AU3850600A (en) | Dalda analogs and their use | |
| WO1992019617A3 (en) | Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use | |
| SE9903997D0 (en) | New compounds | |
| SE9802208D0 (en) | Novel compounds | |
| DE69907419D1 (en) | Antitumorwirkstoffe | |
| ES2135342A1 (en) | Improvements in or relating to the prophylaxis of breast cancer by the administration of raloxifene | |
| RU94044356A (en) | Use of 2-phenyl-3-aroylbenzothiophenes for thrombodulin expression increase to inhibit thrombotic disorder, for protein c activation | |
| RU94045271A (en) | Use of 2-phenyl-3-aroylbenzothiophenes for terner's syndrome inhibition | |
| IL126235A0 (en) | Compounds with growth hormone releasing properties | |
| RU94045156A (en) | Use of 2-phenyl-3-aroylbenzothiophenes for premature sexual maturation inhibition | |
| SE9802209D0 (en) | Novel compounds | |
| EP1121932A4 (en) | Remedies for ocular diseases | |
| YU46302A (en) | Substituted pyrroles | |
| NZ336321A (en) | Use of benzothiophene (raloxifene) for treating breast cancer | |
| AU4944899A (en) | New pharmaceutically active compounds | |
| WO2000010543A3 (en) | Medicament containing platinum complex compounds and the use thereof | |
| NZ503027A (en) | Use of rifamycin derivative for treating mastitis in a domestic animal | |
| NZ337048A (en) | Use of N-[1-methyl-(substituted phenyl)ethyl]-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxamide derivatives to treat prostate cancer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RENW | Renewal (renewal fees accepted) | ||
| RENW | Renewal (renewal fees accepted) | ||
| RENW | Renewal (renewal fees accepted) | ||
| ASS | Change of ownership |
Owner name: ELI LILLY AND COMPANY, US Free format text: OLD OWNER(S): ELI LILLY AND COMPANY; DRAPER, MICHAEL WILLIAM |
|
| S883 | Correction of error according to section 88(3) (mistake in register caused on part of patentee or applicant) |
Free format text: CORRECTION TO INVENTOR (72) |
|
| EXPY | Patent expired |